Oscar Health, Inc. (NYSE:OSCR) COO Steven Wolin Sells 18,607 Shares of Stock

Oscar Health, Inc. (NYSE:OSCRGet Free Report) COO Steven Wolin sold 18,607 shares of the company’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $19.46, for a total value of $362,092.22. Following the sale, the chief operating officer now owns 65,316 shares in the company, valued at approximately $1,271,049.36. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Oscar Health Stock Down 1.5 %

NYSE OSCR opened at $18.93 on Wednesday. Oscar Health, Inc. has a 12 month low of $4.72 and a 12 month high of $23.44. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.29. The firm’s fifty day moving average price is $18.11 and its 200 day moving average price is $14.11.

Oscar Health (NYSE:OSCRGet Free Report) last posted its earnings results on Tuesday, May 7th. The company reported $0.62 EPS for the quarter, topping analysts’ consensus estimates of $0.28 by $0.34. The business had revenue of $2.14 billion for the quarter, compared to analysts’ expectations of $1.99 billion. Oscar Health had a negative return on equity of 5.77% and a negative net margin of 0.82%. The business’s revenue was up 45.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.18) earnings per share. Sell-side analysts anticipate that Oscar Health, Inc. will post -0.04 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. boosted its holdings in shares of Oscar Health by 19.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,125,355 shares of the company’s stock valued at $6,268,000 after acquiring an additional 182,206 shares during the period. Graham Capital Management L.P. purchased a new stake in Oscar Health in the 3rd quarter valued at $894,000. Mirae Asset Global Investments Co. Ltd. boosted its stake in Oscar Health by 270.6% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 265,031 shares of the company’s stock worth $2,425,000 after purchasing an additional 193,512 shares during the period. Dark Forest Capital Management LP purchased a new position in Oscar Health during the 3rd quarter worth $581,000. Finally, National Bank of Canada FI acquired a new position in Oscar Health in the fourth quarter valued at $1,071,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently commented on OSCR. Raymond James initiated coverage on Oscar Health in a research report on Friday, March 22nd. They set an “outperform” rating and a $20.00 price objective for the company. Baird R W raised shares of Oscar Health to a “strong-buy” rating in a research report on Thursday, May 30th. Robert W. Baird initiated coverage on shares of Oscar Health in a report on Thursday, May 30th. They issued an “outperform” rating and a $28.00 price objective on the stock. Wells Fargo & Company boosted their target price on shares of Oscar Health from $20.00 to $24.00 and gave the stock an “overweight” rating in a research note on Thursday, May 9th. Finally, The Goldman Sachs Group raised their price target on Oscar Health from $16.00 to $21.00 and gave the company a “neutral” rating in a research note on Thursday, May 9th. Three research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $18.57.

Get Our Latest Stock Analysis on OSCR

Oscar Health Company Profile

(Get Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

See Also

Insider Buying and Selling by Quarter for Oscar Health (NYSE:OSCR)

Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.